文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Cardiovascular involvement in multisystem inflammatory syndrome in children and midterm follow-up from a pediatric tertiary center in India.

作者信息

Varadarajan Poovazhagi, Solomon Ritchie Sharon, Subramani Seenivasan, Subramanian Ramesh, Srividya Gomathy, Raghunathan Elilarasi

机构信息

Department of Pediatric Intensive Care, Institute of Child Health and Hospital for Children, Madras Medical College, Chennai 600003, Tamil Nādu, India.

Department of Pediatric Cardiology, Institute of Child Health and Hospital for Children, Madras Medical College, Chennai 600003, Tamil Nādu, India.

出版信息

World J Clin Pediatr. 2025 Mar 9;14(1):100453. doi: 10.5409/wjcp.v14.i1.100453.


DOI:10.5409/wjcp.v14.i1.100453
PMID:40059894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11686581/
Abstract

BACKGROUND: In multisystem inflammatory syndrome in children (MIS-C) with coronavirus disease 2019, there was paucity of data from low-income and middle-income countries on cardiovascular involvement and its longitudinal outcomes. We planned to estimate the pattern of cardiovascular involvement among children with MIS-C and its mid-term outcomes. AIM: To determine association between cardiovascular abnormalities and clinical and laboratory parameters. To study the time-line for resolution of various abnormalities. METHODS: In this prospective study done in a tertiary care hospital, 270 were recruited from June 2020 to January 2022. Baseline demographic data and clinical presentation were recorded. Laboratory parameters and echocardiography were done at admission. Follow-up was done at 2 weeks, 3 months, 6 months and 1 year after diagnosis. Descriptive statistics were used for parametric and non-parametric data. Risk factors were identified by multivariate regression analysis. RESULTS: The 211 (78.2%) had cardiac involvement and 102 needed intensive care unit (ICU) admission. Cardiovascular abnormalities observed were shock 123 (45.6%), coronary dilatation 28 (10.4%), coronary aneurysm 77 (28.5%), left ventricular (LV) dysfunction 78 (29.3%), mitral regurgitation (MR) 77 (28.5%) and pericardial effusion 98 (36.3%). Coronary artery aneurysm/dilatation during follow-up at 2 weeks and 1 year were 25.7% and 0.9% respectively. Multivariate regression analysis revealed breathlessness [odds ratio (OR) = 3.91, 95%CI: 1.25-12.21, = 0.019] and hi-flow nasal cannula (HFNC) support (OR = 8.5, 95%CI: 1.06-68.38, = 0.044) as predictors of cardiovascular involvement. Higher mean age (OR = 1.16, 95%CI: 1.02-1.32, = 0.026), breathlessness (OR = 4.99, 95%CI: 2.05-12.20, < 0.001), gallop (OR = 4.45, 95%CI: 0.41-2.52, = 0.016), MR (OR = 3.61, 95%CI: 1.53-8.53, = 0.004) and invasive ventilation (OR = 4.01, 95%CI: 1.28-12.58, = 0.017) were predictive of LV dysfunction. Altered sensorium (OR = 4.96, 95%CI: 2.23-11.02, < 0.001), headache (OR = 6.61, 95%CI: 1.46-29.92, = 0.014), HFNC (OR = 7.03, 95%CI: 2.04-24.29, = 0.002), non-rebreathing mask usage (OR = 21.13, 95%CI: 9.00-49.61, < 0.001) and invasive ventilation (OR = 5.64, 95%CI: 1.42-22.45, = 0.014) were risk factors for shock. Anemia was a risk factor for coronary involvement (OR = 3.09, 95%CI: 1.79- 5.34, < 0.001). CONCLUSION: Significant number of children with MIS-C had cardiovascular involvement contributing to higher ICU management. Although shock resolved quickly, resolution of ventricular function and coronary abnormalities were slower, and hence warrants a structured long-term follow-up protocol.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b492/11686581/4609dcb1a631/100453-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b492/11686581/a35e3c834539/100453-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b492/11686581/2d150109c06b/100453-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b492/11686581/4609dcb1a631/100453-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b492/11686581/a35e3c834539/100453-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b492/11686581/2d150109c06b/100453-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b492/11686581/4609dcb1a631/100453-g003.jpg

相似文献

[1]
Cardiovascular involvement in multisystem inflammatory syndrome in children and midterm follow-up from a pediatric tertiary center in India.

World J Clin Pediatr. 2025-3-9

[2]
Longitudinal Cardiac Outcomes of Multisystem Inflammatory Syndrome in Children: A Systematic Review and Meta-Analysis.

Pediatr Cardiol. 2023-4

[3]
Cardiac involvement in children with paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): data from a prospective nationwide surveillance study.

Swiss Med Wkly. 2023-10-13

[4]
Longitudinal Echocardiographic Follow-Up of a Pediatric Multisystem Inflammatory Syndrome Cohort.

Turk Kardiyol Dern Ars. 2024-4

[5]
Short to midterm follow-up of multi-system inflammatory syndrome in children with special reference to cardiac involvement.

Cardiol Young. 2023-3

[6]
Six-Month Outcomes in the Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children Study.

JAMA Pediatr. 2025-3-1

[7]
Intensive Care Needs and Short-Term Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience from North India.

J Trop Pediatr. 2021-7-2

[8]
Multisystem Inflammatory Syndrome in Children: Follow-Up of a Cohort from North India.

Am J Trop Med Hyg. 2022-2-16

[9]
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.

JAMA. 2021-3-16

[10]
Clinical Profile and Outcomes of Multisystem Inflammatory Syndrome in Children: A Multicentric Observational Study.

Cureus. 2022-9-6

引用本文的文献

[1]
Clinical Characteristics and Outcomes in Multisystemic Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A 12-Month Prospective Study.

Microorganisms. 2025-6-16

本文引用的文献

[1]
Should we be afraid of long-term cardiac consequences in children with multisystem inflammatory syndrome? Experience from subsequent waves of COVID-19.

Eur J Pediatr. 2024-6

[2]
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Covid-19 - Single-Center Experience.

Indian Pediatr. 2023-5-15

[3]
Long-Term Cardiovascular Outcome in Children with MIS-C Linked to SARS-CoV-2 Infection-An Italian Multicenter Experience.

Biology (Basel). 2022-10-8

[4]
Long-Term Cardiovascular Outcomes of Multisystem Inflammatory Syndrome in Children Associated with COVID-19 Using an Institution Based Algorithm.

Pediatr Cardiol. 2023-2

[5]
Multisystem Inflammatory Syndrome Associated With COVID-19 in Children (MIS-C): A Systematic Review of Studies From India.

Indian Pediatr. 2022-7-15

[6]
Cardiac Evaluation in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With COVID-19.

Indian Pediatr. 2022-4-15

[7]
Eastern India Collaboration on Multisystem Inflammatory Syndrome in Children (EICOMISC): A Multicenter Observational Study of 134 Cases.

Front Pediatr. 2022-3-11

[8]
Heart Involvement in Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children: The Retrospective Multicenter Cohort Data.

Front Pediatr. 2022-3-2

[9]
Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19.

Curr Cardiol Rep. 2021-10-1

[10]
A new scoring system for coronary artery abnormalities in Kawasaki disease.

Pediatr Res. 2022-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索